What is Selfapy?
Selfapy is a digital health platform that provides scientifically-proven online therapy courses designed to address mental health conditions such as depression and anxiety. The platform delivers weekly modules grounded in cognitive behavioural therapy (CBT) principles. Users receive support through weekly interactions with Selfapy's clinical psychologists via calls or chat. As a CE-certified medical product, Selfapy is already integrated with and reimbursed by numerous health insurance companies across Germany, highlighting its established credibility and utility within the healthcare system.
How much funding has Selfapy raised?
Selfapy has raised a total of $7.4M across 1 funding round:
Other Financing Round
$7.4M
Other Financing Round (2023): $7.4M with participation from IBB Ventures
Key Investors in Selfapy
IBB Ventures
IBB Ventures is a venture capital firm that invests public funds to support innovative startups in Berlin, promoting the city as a business location. Established in 1997, it focuses on early-stage financing and has a portfolio that includes various ambitious founders and their ideas.
What's next for Selfapy?
The recent major strategic investment in Selfapy signals a pivotal growth phase for the company. This significant backing is expected to fuel further development of its therapeutic offerings, expansion into new markets, and enhancement of its technological infrastructure. The company's focus on evidence-based digital therapy, coupled with its status as a reimbursed medical product, positions it for substantial scaling and impact in the digital mental health sector. Future initiatives will likely concentrate on broadening its user base and deepening its clinical efficacy.
See full Selfapy company page
